Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome-Reference-Cited by-同舟云学术

Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome

Published:2023-01 Issue:1 Volume:29 Page:158-169
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Parry Erin M.^ORCID,Leshchiner Ignaty^ORCID,Guièze Romain^ORCID,Johnson Connor,Tausch Eugen,Parikh Sameer A.^ORCID,Lemvigh Camilla^ORCID,Broséus Julien^ORCID,Hergalant Sébastien^ORCID,Messer Conor^ORCID,Utro Filippo^ORCID,Levovitz Chaya^ORCID,Rhrissorrakrai Kahn,Li Liang,Rosebrock Daniel,Yin Shanye,Deng Stephanie^ORCID,Slowik Kara,Jacobs Raquel,Huang Teddy,Li Shuqiang^ORCID,Fell Geoff^ORCID,Redd Robert^ORCID,Lin Ziao,Knisbacher Binyamin A.^ORCID,Livitz Dimitri^ORCID,Schneider Christof,Ruthen Neil^ORCID,Elagina Liudmila,Taylor-Weiner Amaro^ORCID,Persaud Bria^ORCID,Martinez Aina^ORCID,Fernandes Stacey M.,Purroy Noelia,Anandappa Annabelle J.,Ma Jialin,Hess Julian^ORCID,Rassenti Laura Z.,Kipps Thomas J.,Jain Nitin,Wierda William^ORCID,Cymbalista Florence,Feugier Pierre,Kay Neil E.^ORCID,Livak Kenneth J.^ORCID,Danysh Brian P.^ORCID,Stewart Chip,Neuberg Donna^ORCID,Davids Matthew S.^ORCID,Brown Jennifer R.^ORCID,Parida Laxmi^ORCID,Stilgenbauer Stephan^ORCID,Getz Gad^ORCID,Wu Catherine J.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.nature.com/articles/s41591-022-02113-6.pdf

Reference61 articles.

1. Offin, M. et al. Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes. J. Thorac. Oncol. 14, 1784–1793 (2019).

2. Volta, A. D. et al. Transformation of prostate adenocarcinoma into small-cell neuroendocrine cancer under androgen deprivation therapy: much is achieved but more information is needed. J. Clin. Oncol. 37, 350–351 (2019).

3. Parikh, S. A., Kay, N. E. & Shanafelt, T. D. How we treat Richter syndrome. Blood 123, 1647–1657 (2014).

4. Landau, D. A. et al. Mutations driving CLL and their evolution in progression and relapse. Nature 526, 525–530 (2015).

5. Puente, X. S. et al. Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature 526, 519–524 (2015).

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding splenic B‐cell lymphoma/leukaemia with prominent nucleoli: Diagnosis, underpinnings for disease classification and future directions;British Journal of Haematology;2024-09-10

2. Advances in the understanding of molecular genetics and therapy of Richter transformation in chronic lymphocytic leukemia;Leukemia & Lymphoma;2024-09-02

3. Treatment of Richter transformation—immunotherapy to the rescue?;The Lancet Oncology;2024-09

4. Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in patients with B-cell malignancies: analysis of the Richter transformation subgroup from the multicentre, open-label, phase 1/2 BRUIN study;The Lancet Haematology;2024-09

5. Systematic identification of minor histocompatibility antigens predicts outcomes of allogeneic hematopoietic cell transplantation;Nature Biotechnology;2024-08-21